Johnson & Johnson Innovation and Janssen Research & Development Launch World without Disease QuickFire Challenge
Largest QuickFire competition to date will award up to $500,000 in a research grant and entrance to Johnson & Johnson Innovation, JLABS, to promising transformational healthcare solution Challenge launched at 2016 BIO International Convention during the Bionic Innovation Forum SAN FRANCISCO, June 6, 2016 — Johnson & Johnson Innovation LLC and Janssen Research & Development today announced the launch of the World Without Disease QuickFire challenge.
The competition is the largest and most ambitious QuickFire challenge to date, representing an ongoing commitment to support life science innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases. Johnson & Johnson Innovation will consider global applicants with solutions across the pharmaceutical, medical device and consumer sectors.
The competition seeks to find entrepreneurs, researchers or startup companies who are advancing potentially game-changing, early stage innovations that have the potential to cross traditional boundaries of the pharmaceutical, device or consumer health sectors. The recipient will receive a research grant totaling up to USD 500,000 and entrance to a Johnson & Johnson Innovation, JLABS (JLABS) community.
Johnson & Johnson Innovation and Janssen Research & Development goal is to improve public health and wellness of people around the world. to that effect, they have a passionate and engaged workforce across their consumer, medical device, and pharmaceutical units who are interested in finding and deploying comprehensive, end to end, integrated solutions which take into account the world in which we live today.
Johnson & Johnson Innovation and Janssen Research & Development are bringing together the consumer, medical device and pharmaceutical sectors to award a prize or a series of prizes to the person or team(s) who submits the best idea, technology, or solution that will address a critical health need for the world’s population. The QuickFire Challenge will have a strong emphasis on lung cancer and metabolism.
Solutions will be evaluated based on their ability to meet the following criteria
Address a particular cohort with a critical unmet medical need in Johnson & Johnson’s strategic areas of interest, such as lung cancer and metabolic diseases.
Integrate a novel approach that combines pharmaceutical, devices and/or consumer health solutions.
Address part or all of the spectrum of prevention, interception and cure.
Outline how the award would help them reach a critical milestone within the timeframe of a single year and provide a full “time-to-market” plan for their solution.
Deadline to apply is Aug 31, 2016
Winners will be announced by end of 2016
To apply for the Johnson & Johnson Innovation and Janssen Research & Development’s QuickFire Challenge click here.
